Bosh sahifa8EM • FRA
add
Editas Medicine Inc
Yopilish kursi
1,54 €
Kunlik diapazon
1,52 € - 1,52 €
Yillik diapazon
0,83 € - 5,40 €
Bozor kapitalizatsiyasi
159,89 mln USD
Oʻrtacha hajm
130,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 4,66 mln | 310,40% |
Joriy xarajat | 39,06 mln | -40,11% |
Sof foyda | -76,09 mln | -22,82% |
Sof foyda marjasi | -1,63 ming | 70,07% |
Har bir ulushga tushum | -0,92 | -21,05% |
EBITDA | -33,39 mln | 49,08% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 220,96 mln | -25,39% |
Jami aktivlari | 263,65 mln | -40,13% |
Jami passivlari | 201,23 mln | 37,88% |
Umumiy kapital | 62,42 mln | — |
Tarqatilgan aksiyalar | 83,71 mln | — |
Narxi/balansdagi bahosi | 2,06 | — |
Aktivlardan daromad | -29,17% | — |
Kapitaldan daromad | -67,17% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -76,09 mln | -22,82% |
Operatsiyalardan naqd pul | -47,80 mln | 4,16% |
Sarmoyadan naqd pul | 56,39 mln | 1 288,35% |
Moliyadan naqd pul | -1,44 mln | -848,44% |
Naqd pulning sof oʻzgarishi | 7,15 mln | 113,14% |
Boʻsh pul | -5,77 mln | 75,28% |
Haqida
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
Tashkil etilgan
noy 2013
Xodimlar soni
246
